InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Dupont Jakob, Vice-Président Exécutif, Responsable de la R&D. Insider active across 4 companies, notably Atara Biotherapeutics, Inc.. In total, 19 reports have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €189k. History available since 18 May 2021. The latest transaction was disclosed on 26 March 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dupont Jakob
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
38,741 shares0Common StockSEC:0000950170-24-038102:0
5,074 shares@ US$3.6274.1% of flowCommon StockSEC:0001567619-23-004537:0
141,328 shares0Common StockSEC:0001140361-23-010100:0
3,218 shares@ US$4.493.3% of flowCommon StockSEC:0001140361-22-042381:0
4,124 shares@ US$5.0344.9% of flowCommon StockSEC:0001140361-22-030300:0
3,873 shares@ US$5.3180.024% mcap5.3% of flowCommon StockSEC:0001140361-22-019981:0
78,506 shares0Common StockSEC:0001140361-22-007765:0
5,000 shares@ US$9.5811.8% of flowCommon StockSEC:0001567619-22-004499:0
5,000 shares@ US$9.5811.8% of flowCommon StockSEC:0001567619-22-000568:0
5,000 shares@ US$9.5811.9% of flowCommon StockSEC:0001567619-21-021583:0
2,199 shares@ US$17.11699.3% of flowCommon StockSEC:0001567619-21-020777:0
5,000 shares@ US$9.5811.6% of flowCommon StockSEC:0001567619-21-019331:0
2,152 shares@ US$12.5326.5% of flowCommon StockSEC:0001567619-21-016145:0
5,184 shares@ US$14.5517.3% of flowCommon StockSEC:0001209191-21-034428:0
2,500 sharesCommon StockSEC:0001140361-16-047651:0
2,500 sharesCommon StockSEC:0001140361-16-047651:1
2,092 sharesCommon StockSEC:0001140361-16-047340:0
69 sharesCommon StockSEC:0001140361-16-047340:1
1 sharesCommon StockSEC:0001140361-16-047340:2
19 of 19 declarations
About Dupont Jakob
Dupont Jakob is Executive Vice President, Head of R&D. He has made 19 filings in total, and across the sampled recent filings covering 2016-01-08 to 2024-03-28, the amounts shown are 0 in buys and 188988 in sells, with a dominant transaction nature of Sale. The companies mentioned in the filings are Atara Biotherapeutics, Inc., OncoMed Pharmaceuticals Inc, and Pyxis Oncology, Inc.
